| Literature DB >> 16356827 |
Daniel Floryk1, Eliezer Huberman.
Abstract
Inosine 5'-monophosphate dehydrogenase inhibitors including mycophenolic acid (MPA) are effective inducers of terminal differentiation in a variety of distinct human tumor cell types. Here, we report that MPA also induces such a differentiation in the androgen-independent prostate cancer derived cell line DU145. MPA evoked replication arrest and accumulation of the DU145 cells in the S-phase of the cell cycle. The inhibitor also induced the expression of CD55, clusterin, granulophysin, glucose-regulated protein 78, vasoactive intestinal polypeptide and prostate-specific transglutaminase, which are differentiation markers associated with the phenotype of normal prostate cells. We suggest that inosine 5'-monophosphate dehydrogenase inhibitors, which are already used for the treatment of other diseases, may be used as potential differentiation therapy drugs to control prostate cancer.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16356827 DOI: 10.1016/j.canlet.2005.01.006
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679